methyl (13S,15R,17S)-17-ethyl-13-[(1R,9R,10R,12R,19S)-10-(hydrazinecarbonyl)-10-hydroxy-5-methoxy-8,12-dimethyl-8,16-diazapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2,4,6,13-tetraen-4-yl]-17-hydroxy-1,11-diazatetracyclo[13.3.1.04,12.05,10]nonadeca-4(12),5,7,9-tetraene-13-carboxylate

C42H54N6O6 — CID 122696709

IUPACmethyl (13S,15R,17S)-17-ethyl-13-[(1R,9R,10R,12R,19S)-10-(hydrazinecarbonyl)-10-hydroxy-5-methoxy-8,12-dimethyl-8,16-diazapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2,4,6,13-tetraen-4-yl]-17-hydroxy-1,11-diazatetracyclo[13.3.1.04,12.05,10]nonadeca-4(12),5,7,9-tetraene-13-carboxylate
SMILESCC[C@]1(O)C[C@@H]2CN(CCc3c([nH]c4ccccc34)[C@@](C(=O)OC)(c3cc4c(cc3OC)N(C)[C@@H]3[C@]45CCN4CC=C[C@@](C)(C[C@]3(O)C(=O)NN)[C@H]45)C2)C1
InChIInChI=1S/C42H54N6O6/c1-6-39(51)20-25-21-41(37(50)54-5,33-27(12-16-47(22-25)24-39)26-10-7-8-11-30(26)44-33)29-18-28-31(19-32(29)53-4)46(3)35-40(28)14-17-48-15-9-13-38(2,34(40)48)23-42(35,52)36(49)45-43/h7-11,13,18-19,25,34-35,44,51-52H,6,12,14-17,20-24,43H2,1-5H3,(H,45,49)/t25-,34-,35+,38-,39-,40+,41-,42+/m0/s1
InChIKeyGDMQRXKLTSVZKZ-GGAOMZCYSA-N
MW738.93 g/mol
LogP2.88
Rot. Bonds5

About methyl (13S,15R,17S)-17-ethyl-13-[(1R,9R,10R,12R,19S)-10-(hydrazinecarbonyl)-10-hydroxy-5-methoxy-8,12-dimethyl-8,16-diazapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2,4,6,13-tetraen-4-yl]-17-hydroxy-1,11-diazatetracyclo[13.3.1.04,12.05,10]nonadeca-4(12),5,7,9-tetraene-13-carboxylate

methyl (13S,15R,17S)-17-ethyl-13-[(1R,9R,10R,12R,19S)-10-(hydrazinecarbonyl)-10-hydroxy-5-methoxy-8,12-dimethyl-8,16-diazapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2,4,6,13-tetraen-4-yl]-17-hydroxy-1,11-diazatetracyclo[13.3.1.04,12.05,10]nonadeca-4(12),5,7,9-tetraene-13-carboxylate (PubChem CID 122696709) has the molecular formula C42H54N6O6 and a molecular weight of 738.93 g/mol. Its IUPAC name is methyl (13S,15R,17S)-17-ethyl-13-[(1R,9R,10R,12R,19S)-10-(hydrazinecarbonyl)-10-hydroxy-5-methoxy-8,12-dimethyl-8,16-diazapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2,4,6,13-tetraen-4-yl]-17-hydroxy-1,11-diazatetracyclo[13.3.1.04,12.05,10]nonadeca-4(12),5,7,9-tetraene-13-carboxylate.

Molecular Properties

Compound Namemethyl (13S,15R,17S)-17-ethyl-13-[(1R,9R,10R,12R,19S)-10-(hydrazinecarbonyl)-10-hydroxy-5-methoxy-8,12-dimethyl-8,16-diazapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2,4,6,13-tetraen-4-yl]-17-hydroxy-1,11-diazatetracyclo[13.3.1.04,12.05,10]nonadeca-4(12),5,7,9-tetraene-13-carboxylate
PubChem CID122696709
Molecular FormulaC42H54N6O6
Molecular Weight738.93 g/mol
Exact Mass738.41
IUPAC Namemethyl (13S,15R,17S)-17-ethyl-13-[(1R,9R,10R,12R,19S)-10-(hydrazinecarbonyl)-10-hydroxy-5-methoxy-8,12-dimethyl-8,16-diazapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2,4,6,13-tetraen-4-yl]-17-hydroxy-1,11-diazatetracyclo[13.3.1.04,12.05,10]nonadeca-4(12),5,7,9-tetraene-13-carboxylate
SMILESCC[C@]1(O)C[C@@H]2CN(CCc3c([nH]c4ccccc34)[C@@](C(=O)OC)(c3cc4c(cc3OC)N(C)[C@@H]3[C@]45CCN4CC=C[C@@](C)(C[C@]3(O)C(=O)NN)[C@H]45)C2)C1
InChIInChI=1S/C42H54N6O6/c1-6-39(51)20-25-21-41(37(50)54-5,33-27(12-16-47(22-25)24-39)26-10-7-8-11-30(26)44-33)29-18-28-31(19-32(29)53-4)46(3)35-40(28)14-17-48-15-9-13-38(2,34(40)48)23-42(35,52)36(49)45-43/h7-11,13,18-19,25,34-35,44,51-52H,6,12,14-17,20-24,43H2,1-5H3,(H,45,49)/t25-,34-,35+,38-,39-,40+,41-,42+/m0/s1
InChIKeyGDMQRXKLTSVZKZ-GGAOMZCYSA-N
XLogP2.88
TPSA156.62 Ų
H-Bond Donors5
H-Bond Acceptors10
Rotatable Bonds5
Heavy Atoms54
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500738.93
LogP ≤ 52.88
H-Bond Donors ≤ 55
H-Bond Acceptors ≤ 1010

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'acyl_hydrazine', 'substructure': 'N/A'}, {'alert_name': 'hydrazine', 'substructure': 'N/A'}, {'alert_name': 'isolated_alkene', 'substructure': 'N/A'}, {'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'}

Analyze methyl (13S,15R,17S)-17-ethyl-13-[(1R,9R,10R,12R,19S)-10-(hydrazinecarbonyl)-10-hydroxy-5-methoxy-8,12-dimethyl-8,16-diazapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2,4,6,13-tetraen-4-yl]-17-hydroxy-1,11-diazatetracyclo[13.3.1.04,12.05,10]nonadeca-4(12),5,7,9-tetraene-13-carboxylate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of methyl (13S,15R,17S)-17-ethyl-13-[(1R,9R,10R,12R,19S)-10-(hydrazinecarbonyl)-10-hydroxy-5-methoxy-8,12-dimethyl-8,16-diazapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2,4,6,13-tetraen-4-yl]-17-hydroxy-1,11-diazatetracyclo[13.3.1.04,12.05,10]nonadeca-4(12),5,7,9-tetraene-13-carboxylate?
The IUPAC name of methyl (13S,15R,17S)-17-ethyl-13-[(1R,9R,10R,12R,19S)-10-(hydrazinecarbonyl)-10-hydroxy-5-methoxy-8,12-dimethyl-8,16-diazapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2,4,6,13-tetraen-4-yl]-17-hydroxy-1,11-diazatetracyclo[13.3.1.04,12.05,10]nonadeca-4(12),5,7,9-tetraene-13-carboxylate (CID 122696709) is methyl (13S,15R,17S)-17-ethyl-13-[(1R,9R,10R,12R,19S)-10-(hydrazinecarbonyl)-10-hydroxy-5-methoxy-8,12-dimethyl-8,16-diazapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2,4,6,13-tetraen-4-yl]-17-hydroxy-1,11-diazatetracyclo[13.3.1.04,12.05,10]nonadeca-4(12),5,7,9-tetraene-13-carboxylate.
What is the SMILES notation for methyl (13S,15R,17S)-17-ethyl-13-[(1R,9R,10R,12R,19S)-10-(hydrazinecarbonyl)-10-hydroxy-5-methoxy-8,12-dimethyl-8,16-diazapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2,4,6,13-tetraen-4-yl]-17-hydroxy-1,11-diazatetracyclo[13.3.1.04,12.05,10]nonadeca-4(12),5,7,9-tetraene-13-carboxylate?
The canonical SMILES for methyl (13S,15R,17S)-17-ethyl-13-[(1R,9R,10R,12R,19S)-10-(hydrazinecarbonyl)-10-hydroxy-5-methoxy-8,12-dimethyl-8,16-diazapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2,4,6,13-tetraen-4-yl]-17-hydroxy-1,11-diazatetracyclo[13.3.1.04,12.05,10]nonadeca-4(12),5,7,9-tetraene-13-carboxylate is CC[C@]1(O)C[C@@H]2CN(CCc3c([nH]c4ccccc34)[C@@](C(=O)OC)(c3cc4c(cc3OC)N(C)[C@@H]3[C@]45CCN4CC=C[C@@](C)(C[C@]3(O)C(=O)NN)[C@H]45)C2)C1.
What is the InChIKey of methyl (13S,15R,17S)-17-ethyl-13-[(1R,9R,10R,12R,19S)-10-(hydrazinecarbonyl)-10-hydroxy-5-methoxy-8,12-dimethyl-8,16-diazapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2,4,6,13-tetraen-4-yl]-17-hydroxy-1,11-diazatetracyclo[13.3.1.04,12.05,10]nonadeca-4(12),5,7,9-tetraene-13-carboxylate?
The InChIKey is GDMQRXKLTSVZKZ-GGAOMZCYSA-N. The full InChI is InChI=1S/C42H54N6O6/c1-6-39(51)20-25-21-41(37(50)54-5,33-27(12-16-47(22-25)24-39)26-10-7-8-11-30(26)44-33)29-18-28-31(19-32(29)53-4)46(3)35-40(28)14-17-48-15-9-13-38(2,34(40)48)23-42(35,52)36(49)45-43/h7-11,13,18-19,25,34-35,44,51-52H,6,12,14-17,20-24,43H2,1-5H3,(H,45,49)/t25-,34-,35+,38-,39-,40+,41-,42+/m0/s1.
What are the key properties of methyl (13S,15R,17S)-17-ethyl-13-[(1R,9R,10R,12R,19S)-10-(hydrazinecarbonyl)-10-hydroxy-5-methoxy-8,12-dimethyl-8,16-diazapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2,4,6,13-tetraen-4-yl]-17-hydroxy-1,11-diazatetracyclo[13.3.1.04,12.05,10]nonadeca-4(12),5,7,9-tetraene-13-carboxylate?
methyl (13S,15R,17S)-17-ethyl-13-[(1R,9R,10R,12R,19S)-10-(hydrazinecarbonyl)-10-hydroxy-5-methoxy-8,12-dimethyl-8,16-diazapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2,4,6,13-tetraen-4-yl]-17-hydroxy-1,11-diazatetracyclo[13.3.1.04,12.05,10]nonadeca-4(12),5,7,9-tetraene-13-carboxylate has a molecular weight of 738.93 g/mol, XLogP of 2.88, 5 rotatable bonds, 5 hydrogen bond donors, and 10 hydrogen bond acceptors.
Where does this data come from?
All data for methyl (13S,15R,17S)-17-ethyl-13-[(1R,9R,10R,12R,19S)-10-(hydrazinecarbonyl)-10-hydroxy-5-methoxy-8,12-dimethyl-8,16-diazapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2,4,6,13-tetraen-4-yl]-17-hydroxy-1,11-diazatetracyclo[13.3.1.04,12.05,10]nonadeca-4(12),5,7,9-tetraene-13-carboxylate is sourced from PubChem (CID 122696709), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).